Achieving the UNAIDS goals by 2030 in people living with HIV: A simulation model to support the prioritization of health care interventions

Pep Coll, Miguel Á. Casado(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), Antonio Castro-Gómez(Gilead Sciences (Spain)), Estebán Martínez(Instituto de Salud Carlos III), José Manuel Martínez Sesmero, Raquel Domínguez‐Hernández(Pharmacoeconomics and Health Outcomes Research Iberia (Spain)), Inmaculada Jarrín(Instituto de Salud Carlos III)
Enfermedades Infecciosas y Microbiología Clínica
November 3, 2022
10.1016/j.eimc.2022.07.012
Cited by 12

Related Papers

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
|Clinical Microbiology and Infection|2020|128